Food research international (Ottawa, Ont.)Sep 1, 2026

Bifidobacterium pseudocatenulatum AL44 may improve memory problems caused by D-galactose by affecting the gut-brain connection

Gut-Brain Axis Weekly Brief ↗PubMed ↗DOI ↗

Updated Sep 2, 2026

Abstract

Bifidobacterium pseudocatenulatum AL44 treatment improved spatial learning and memory in D-galactose-treated mice.

AL44 significantly reduced hippocampal neuronal damage and neuroinflammation.
The intervention increased the expression of brain-derived neurotrophic factor (BDNF) and synaptic proteins.
AL44 treatment was associated with decreased apoptosis through modulation of specific signaling pathways.
Gut microbiota remodeling occurred, with notable enrichment of Bacteroides and improved intestinal barrier integrity.
The treatment led to a shift in systemic metabolic profiles, notably increasing levels of citrulline, betaine, and kynurenine.
Fecal microbiota transplantation indicated that the neuroprotective effects of AL44 could be transferred via its modulated gut microbiota.

Simplified

Age-related cognitive decline, particularly deficits in learning and memory, has become a major health challenge among older adults. Probiotics have emerged as potential dietary interventions for maintaining cognitive resilience. This study investigated the neuroprotective effects of Bifidobacterium pseudocatenulatum AL44 against cognitive dysfunction in D-galactose (D-gal)-treated mice and elucidated the underlying gut microbiota-brain mechanisms. AL44 intervention markedly improved spatial learning and memory, attenuated hippocampal neuronal damage, and suppressed neuroinflammation and oxidative stress. Furthermore, AL44 upregulated the expression of brain-derived neurotrophic factor (BDNF), neuronal nuclei (NeuN), and synaptic proteins, while attenuating apoptosis through modulation of the B-cell lymphoma 2 (Bcl-2)/Bcl-2-associated X protein/cysteine-aspartic acid protease 3 signaling pathway. These neuroprotective effects were linked to gut microbiota remodeling, characterized by the enrichment of Bacteroides, preservation of intestinal barrier integrity, and reduced circulating endotoxin levels. Moreover, AL44 treatment reshaped systemic metabolic profiles, particularly amino acid metabolism, leading to increased levels of citrulline, betaine, and kynurenine. Fecal microbiota transplantation confirmed that these neuroprotective effects were transferable via AL44-modulated gut microbiota, supporting the hypothesis that microbiota remodeling contributes to the neuroprotective effects associated with AL44 treatment. These results position AL44 as a promising probiotic candidate for the dietary management of age-related cognitive decline via modulation of the gut-brain axis.

Full Text

Full text is available at the source.

View Full Text ↗

Featured in

Gut-Brain AxisIssue #53

Your gut bacteria may be steering Alzheimer's and Parkinson's through a molecular relay system

↗

Bifidobacterium pseudocatenulatum AL44 may improve memory problems caused by D-galactose by affecting the gut-brain connection

Abstract

Full Text

Featured in

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the gut-brain axis brief